New research could help heart failure patients get safer surgery

NCT ID NCT04489355

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 260 patients with ischemic cardiomyopathy (a weak heart due to blocked arteries) who had heart surgery. The goal was to develop a personalized approach to choose the best type of surgery and predict risks and outcomes. Researchers used imaging, blood tests, and heart tissue samples to create models that could lower complication rates and improve long-term results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)

What this could lead to

If successful, this research could help doctors better predict which patients with heart failure will benefit most from specific heart surgeries, potentially reducing complications and improving recovery.

What could go wrong

This is a completed observational study, not a treatment trial. The findings may not apply to all patients, and the models developed need further testing before they can be used in routine care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiomyopathy cardiovascular disorder congestive heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tomsk National Research Medical Center of the Russian Academy of Sciences

    Tomsk, 634012, Russia